(Formerly known as Central Clinical School)
 |
| Professor Anne Holland in clinic |
The Society Medal was conceived as an acknowledgement of excellence in fields other than research, i.e. for the advancement of the practice of thoracic medicine in its widest sense by outstanding teaching or advocacy, and first awarded in 1992.
Professor Holland is Professor of Physiotherapy at Monash University and Alfred Health in Melbourne, and a National Health and Medical Research Council (NHMRC) Leadership Fellow.
 |
| Research group leaders in the Department of Immunology and Pathology share their thoughts on mentoring. L-R upper row: A/Prof Margaret Hibbs, Prof Nicola Harris, A/Prof Natasha Smallwood, Prof Anne Holland; L-R lower row: Prof David Tarlinton, A/Prof Menno van Zelm, Dr Malcolm Starkey. |
The topic of women in science usually draws immediate mention of Marie Curie, the first person to win two Nobel Prizes, first in Physics in 1903 (with her husband Pierre), and then in Chemistry in 1911. Or more recently, Jennifer Doudna and Emmanuelle Charpentier’s ground-breaking work in gene editing, which won them the 2020 Nobel Prize in Chemistry. Their win marked the first time a science‐related Nobel Prize was shared by women and no men.
 |
| Research shows contact athletes are returning to play too soon. Image: Shutterstock |
 |
Lead and senior authors on the pregnancy and MS medication paper, Drs Wei Yeh and Vilija Jokubaitis. See video (1:44 min). |
A recent study by Monash University has highlighted the benefit for pregnant women with MS who continue with a disease modifying treatment during and after pregnancy.
Using data from the international MSBase registry, the findings published in Neurology, revealed that women with MS who continued to take natalizumab (Tysabri) through and after their pregnancy had a decrease in relapse rates by up to 89 per cent. In contrast, women with MS who stopped taking natalizumab (Tysabri) and another therapy, fingolimod (Gilenya), before conception had an increase in relapse rates.
 |
| Bonnie Dopheide |
Dr Michelle Zajac, Senior Research Manager, CCS, writes:
Bonnie started as an Administration Officer in 2012 but quickly moved into a Laboratory Operations role with the Australian Centre for Blood Diseases and Departments of Medicine and Surgery supporting laboratory operations and Occupational Health and Safety Compliance as part of CCS’s Research and Laboratory Operations Team.
